Bank of New York Mellon Corp - AVEO PHARMACEUTICALS INC ownership

AVEO PHARMACEUTICALS INC's ticker is AVEO and the CUSIP is 053588307. A total of 79 filers reported holding AVEO PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.06 and the average weighting 0.2%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of AVEO PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2022$803,308
+504.0%
53,733
+232.7%
0.00%
Q3 2022$133,000
+70.5%
16,151
+28.5%
0.00%
Q3 2021$78,000
-42.6%
12,564
-39.0%
0.00%
Q2 2021$136,000
-68.6%
20,584
-65.1%
0.00%
Q1 2021$433,000
+27.7%
59,049
+0.7%
0.00%
Q4 2020$339,000
+9.4%
58,613
+12.3%
0.00%
Q3 2020$310,000
+42.2%
52,213
+23.0%
0.00%
Q2 2020$218,00042,4330.00%
Other shareholders
AVEO PHARMACEUTICALS INC shareholders Q3 2022
NameSharesValueWeighting ↓
AIGH Capital Management LLC 2,739,255$22,544,0007.01%
Worth Venture Partners, LLC 685,026$5,638,0003.45%
NEA Management Company, LLC 3,952,957$32,533,0001.62%
Birchview Capital, LP 140,000$1,152,0000.81%
Rubric Capital Management LP 1,664,667$13,700,0000.69%
EAM Investors, LLC 380,691$3,133,0000.68%
GLOBEFLEX CAPITAL L P 368,520$3,033,0000.52%
X-Square Capital, LLC 92,283$759,0000.48%
EAM Global Investors LLC 211,759$1,743,0000.46%
J. Goldman & Co LP 656,161$5,400,0000.26%
View complete list of AVEO PHARMACEUTICALS INC shareholders